Our new research in @JNNP_BMJ: Does #FolicAcid reduce birth defects risk for women on #ASM? Our #TargetTrial emulation shows timing is everything.
✅ 1-12 weeks PRE-conception: 45% risk reduction.
❌ Post-conception: No significant effect .
Direct link to our findings: [Link]

1
16














